Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations

C Ahlgren1, A Odén, K Torén

  • 1Institute of Neuroscience and Physiology, Sahlgrenska University Hospital, Gothenburg, Sweden. cecilia.ahlgren@neuro.gu.se

Abstract

Insights

Mass vaccinations did not alter multiple sclerosis (MS) incidence despite reduced viral infections. An increasing background MS incidence may mask potential vaccination benefits.

Area of Science:

  • Neurology
  • Epidemiology
  • Immunology

Background:

  • Viral childhood infections are implicated in multiple sclerosis (MS) pathogenesis.
  • Swedish vaccination programs significantly reduced measles, mumps, and rubella incidence from the 1970s/1981 onwards.

Purpose of the Study:

  • To investigate if vaccination-induced reductions in viral infections impact MS incidence.
  • To evaluate potential beneficial or harmful effects of mass vaccinations on public health.

Main Methods:

  • Study included 534 MS patients born between 1959-1990.
  • Compared unvaccinated cohorts with four cohorts based on vaccination programs (251 MS patients).

Main Results:

  • No significant changes in MS incidence were detected in relation to vaccination programs.
  • A significant, age-dependent increase in background MS incidence was observed.

Conclusions:

  • Current data shows no evidence that reduced viral infections influenced MS incidence.
  • An increasing background MS incidence of unknown origin might obscure a potential MS risk reduction from mass vaccinations.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Vaccinations01:51

Vaccinations

Overview
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.